Cite
HARVARD Citation
Borroni, E. et al. (n.d.). P4–312: Preclinical characterization of RO4602522, a novel, selective and orally active monoamine oxidase type B inhibitor for the treatment of Alzheimer's disease. Alzheimer's & dementia. p. P818. [Online].